ExLibris header image
SFX Logo
Title: An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Becker, J C yr:1996


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Koehne, G. "Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation." Bone marrow transplantation 19.2 (1997): 149-56. Link to Full Text for this item Link to SFX for this item
2. Neal, Zane C C. "NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy." Cancer immunology, immunotherapy 53.1 (2003): 41-52. Link to Full Text for this item Link to SFX for this item
3. Holden, SA. "Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents." Clinical cancer research 7.9 (2001): 2862-2869. Link to SFX for this item
4. Durmus, T. "Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma." Molecular cancer therapeutics 8.8 (2009): 2392-2401. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.